Follow
Celine Marielle Laffont
Celine Marielle Laffont
Indivior
Verified email at indivior.com
Title
Cited by
Cited by
Year
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
K Brendel, E Comets, C Laffont, C Laveille, F Mentré
Pharmaceutical research 23, 2036-2049, 2006
3772006
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure
JA Taylor, FS Vom Saal, WV Welshons, B Drury, G Rottinghaus, PA Hunt, ...
Environmental health perspectives 119 (4), 422-430, 2011
3222011
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
BR Haight, SM Learned, CM Laffont, PJ Fudala, Y Zhao, AS Garofalo, ...
The Lancet 393 (10173), 778-790, 2019
2302019
Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004
K Brendel, C Dartois, E Comets, A Lemenuel-Diot, C Laveille, ...
Clinical pharmacokinetics 46, 221-234, 2007
2152007
Intestinal secretion is a major route for parent ivermectin elimination in the rat
CM Laffont, PL Toutain, M Alvinerie, A Bousquet-Mélou
Drug metabolism and disposition 30 (6), 626-630, 2002
1342002
Licking behaviour and environmental contamination arising from pour-on ivermectin for cattle
CM Laffont, M Alvinerie, A Bousquet-Mélou, PL Toutain
International Journal for Parasitology 31 (14), 1687-1692, 2001
1282001
Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey
C Dartois, K Brendel, E Comets, CM Laffont, C Laveille, B Tranchand, ...
British journal of clinical pharmacology 64 (5), 603-612, 2007
1092007
Evaluation of different tests based on observations for external model evaluation of population analyses
K Brendel, E Comets, C Laffont, F Mentré
Journal of pharmacokinetics and pharmacodynamics 37, 49-65, 2010
1032010
Gentamicin Nephrotoxicity – A Comparison of In Vitro Findings with In VivoExperiments in Equines
MR Van der Harst, S Bull, CM Laffont, WR Klein
Veterinary research communications 29, 247-261, 2005
712005
Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic–pharmacodynamic analysis and Monte Carlo simulations
D Khachman, JM Conil, B Georges, S Saivin, G Houin, PL Toutain, ...
Journal of antimicrobial chemotherapy 66 (8), 1798-1809, 2011
672011
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure
A Schmitt, L Gladieff, CM Laffont, A Evrard, JC Boyer, A Lansiaux, ...
J Clin Oncol 28 (30), 4568-4574, 2010
632010
A pharmacokinetic model to document the actual disposition of topical ivermectin in cattle
CM Laffont, A Bousquet‐mélou, D Bralet, M Alvinerie, J Fink-Gremmels, ...
Veterinary research 34 (4), 445-460, 2003
622003
Population pharmacokinetic modeling after repeated administrations of RBP‐6000, a new, subcutaneously injectable, long‐acting, sustained‐release formulation of buprenorphine …
CM Laffont, R Gomeni, C Heidbreder, JP Jones Iii, AF Nasser
The Journal of Clinical Pharmacology 56 (7), 806-815, 2016
602016
RB-US-13-0001 Study Investigators.(2019). Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: A multicentre, randomised, double-blind …
BR Haight, SM Learned, CM Laffont, PJ Fudala, Y Zhao, AS Garofalo, ...
Lancet 393 (10173), 778-790, 0
50
Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of …
CM Laffont, R Gomeni, B Zheng, C Heidbreder, PJ Fudala, AF Nasser
Clinical pharmacokinetics 53, 533-543, 2014
472014
A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection
MW Sadiq, EI Nielsen, D Khachman, JM Conil, B Georges, G Houin, ...
Journal of pharmacokinetics and pharmacodynamics 44, 69-79, 2017
452017
Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm
J Bertrand, E Comets, CM Laffont, M Chenel, F Mentré
Journal of pharmacokinetics and pharmacodynamics 36, 317-339, 2009
442009
Population pharmacokinetic modeling and simulation to guide dose selection for RBP‐7000, a new sustained‐release formulation of risperidone
CM Laffont, R Gomeni, B Zheng, C Heidbreder, PJ Fudala, AF Nasser
The Journal of Clinical Pharmacology 55 (1), 93-103, 2015
362015
Use of Monte Carlo simulation to determine pharmacodynamic cutoffs of amoxicillin to establish a breakpoint for antimicrobial susceptibility testing in pigs
JF Rey, CM Laffont, S Croubels, P De Backer, C Zemirline, E Bousquet, ...
American Journal of Veterinary Research 75 (2), 124-131, 2014
352014
Development of a complex parent-metabolite joint population pharmacokinetic model
J Bertrand, CM Laffont, F Mentré, M Chenel, E Comets
The AAPS journal 13, 390-404, 2011
352011
The system can't perform the operation now. Try again later.
Articles 1–20